Apolipoproteins E < Apomorphine < Apoptosis

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000010 (1999)	F. Durif [France] ; M. Vidailhet ; B. Debilly ; Yves Agid [France]	Worsening of levodopa-induced dyskinesias by motor and mental tasks.
000024 (1999)	N. Vaserman-Lehuédé [France] ; M. Vérin	Shoulder pain in patients with Parkinson's disease.
000033 (1999)	O K Hassani [France] ; J. Féger	Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
000069 (1999)	Olga Corti [France] ; Amelia Sánchez-Capelo [France] ; Philippe Colin [France] ; Naïma Hanoun [France] ; Michel Hamon [France] ; Jacques Mallet [France]	Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
000198 (2001)	N. Callizot [France] ; J L Guénet ; C. Baillet ; J M Warter ; P. Poindron	The frissonnant mutant mouse, a model of dopamino-sensitive, inherited motor syndrome.
000362 (2003)	Yassine Darbaky [France] ; Claude Forni ; Marianne Amalric ; Christelle Baunez	High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task.
000465 (1992)	F. Lisovoski [France] ; C. Haby ; E. Borrelli ; C. Schleef ; M O Revel ; C. Hindelang ; J. Zwiller	Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
000564 (2005)	Frédéric Libert [France] ; François Coudoré ; Damien Richard ; Franck Durif ; Alain Eschalier	Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine.
000620 (2006)	Emuri Abe ; Jean-Claude Alvarez	Sensitive quantification of apomorphine in human plasma using a LC-ESI-MS-MS method.
000631 (????)	J L Montastruc [France]	Recent advances in the clinical pharmacology of Parkinson's disease.
000661 (2006)	S. Drapier [France] ; M. Vérin	[Continuous subcutaneous infusion of apomorphine for the treatment of Parkinson's disease].
000713 (1992)	O. Rascol [France] ; U. Sabatini ; F. Chollet ; P. Celsis ; J L Montastruc ; J P Marc-Vergnes ; A. Rascol	Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
000718 (1991)	J L Montastruc [France] ; O. Rascol ; J M Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. Rascol	Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
000744 (1991)	F. Durif [France] ; E. Jeanneau ; F. Serre-Debeauvais ; D. Deffond ; A. Eschalier ; M. Tournilhac	Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease.
000985 (1991)	U. Sabatini ; O. Rascol ; P. Celsis ; G. Houin ; A. Rascol ; J P Marc-Vergnes ; J L Montastruc	Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.
000A90 (2010)	B. Greco [France] ; S. Lopez ; H. Van Der Putten ; P J Flor ; M. Amalric	Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
000B01 (2010)	Olivier Rascol [France] ; Jean-Philippe Azulay ; Olivier Blin ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Pierre Césaro ; Philippe Damier ; Bérengère Debilly ; Frank Durif ; Monique Galitzky ; Jean-Marie Grouin ; Sylvie Pennaforte ; Gabriel Villafane ; Sadek Yaici ; Yves Agid [France]	Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
000C37 (2011)	Estelle Dellapina [France] ; Angélique Gerdelat-Mas ; Fabienne Ory-Magne ; Laure Pourcel ; Monique Galitzky ; Fabienne Calvas ; Marion Simonetta-Moreau ; Claire Thalamas ; Pierre Payoux ; Christine Brefel-Courbon	Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
000D74 (2012)	Sophie Drapier [France] ; Anne-Sophie Gillioz ; Emmanuelle Leray ; Julie Péron ; Tiphaine Rouaud ; Annaig Marchand ; Marc Vérin	Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.
001052 (2013)	C. Regnier-Delplace [France] ; O. Thillaye Du Boullay ; F. Siepmann ; B. Martin-Vaca ; N. Degrave ; P. Demonchaux ; O. Jentzer ; D. Bourissou ; J. Siepmann	PLGA microparticles with zero-order release of the labile anti-Parkinson drug apomorphine.
001068 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Apomorphine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Apomorphine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024